- NASDAQ:TLRY dropped by a further 9.83% on Friday to close out a devastating week for the stock.
- A glaring analyst warning and downgrade has scared retail investors off of the stock.
- Tilray’s upcoming earnings call should shed some light on its reported merger with Aphria.
NASDAQ:TLRY investors experienced the whole spectrum of emotions as the Canadian cannabis giant skyrocketed to a 52-week high of $67.00 on Wednesday before rapidly deflating to finish the week at $29.00. The three-day drop represented 56% drop in the stock’s value and the sudden surge has dramatically placed the 50-day and 200-day moving averages out of sorts. Until the recent spike in price, Tilray had been trading in the low single digits for the better part of 2020 and hadn’t seen double digits since before the market crash in March.
One of the catalysts for Tilray’s sudden plunge was the harsh assessment by GLJ Research analyst Gordon Johnson. Regarding Tilray’s prospects, Johnson was not shy about his negative outlook stating that a $0 price forecast is very much a realistic outcome in the short-term. Johnson called Tilray’s future past 2022 “dismal”, and encouraged investors to sell their shares as quickly as possible. Johnson’s harsh analysis of Tilray added to the downward momentum the stock was already experiencing since Wednesday.
TLRY stock chart
It’s not all negative news for Tilray, as its upcoming merger with Aphria (NASDAQ:APHA) should help to stave off any sort of imminent danger of bankruptcy. Tilray has also continued to advance its reach across Europe, with recent deals to supply medical marijuana to Portugal and the United Kingdom, more markets should be on the way in the near future. Despite all of these prospects, it is often difficult for investors to ignore a negative forecast like the one that was provided by Johnson, so shareholders may continue to experience short-term pain, at least until Tilray’s earnings call on February 17th.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD corrects toward 0.6850, awaits US PCE Price Index
AUD/USD is falling back toward 0.6850 in Friday's Asian trading, reversing from near 19-month peak. A tepid US Dollar bounce drags the pair lower but the downside appears called by the latest Chinese stimulus measures, which boost risk sentiment ahead of US PCE data.
USD/JPY pares gains below 145.50 after Tokyo CPI inflation data
USD/JPY is paring back gains to trade below 145.50 in the Asian session on Friday, as Tokyo CPI inflation data keep hopes of BoJ rate hikes alive. However, intensifying risk flows on China's policy optimism support the pair's renewed upside. The focus shifts to the US PCE inflation data.
Gold price holds steady near record peak; looks to US PCE data from fresh impetus
Gold price consolidates below the all-time high set on Thursday amid overbought conditions on the daily chart and the risk-on mood, though dovish Fed expectations continue to act as a tailwind. Bulls, meanwhile, prefer to wait for the release of the US PCE Price Index before placing fresh bets.
Ethereum could retest $2,707 resistance following increasing ETF inflows and uptrend in funding rates
Ethereum traded around $2,640 on Thursday, up more than 2% following increased bullish bias among investors, as evidenced by ETH ETF net inflows and an uptrend in funding rates. However, investors may be wary of a potential correction from ETH's rising exchange reserve.
RBA widely expected to keep key interest rate unchanged amid persisting price pressures
The Reserve Bank of Australia is likely to continue bucking the trend adopted by major central banks of the dovish policy pivot, opting to maintain the policy for the seventh consecutive meeting on Tuesday.
Five best Forex brokers in 2024
VERIFIED Choosing the best Forex broker in 2024 requires careful consideration of certain essential factors. With the wide array of options available, it is crucial to find a broker that aligns with your trading style, experience level, and financial goals.